Bruce Dale Weintraub
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$6.3MFederal grants as PI11 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
11 awards · $6.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 23, 2021 | NIH | SBIR Phase II Novel Long Acting rhTSH Superagonist Analogs for Improved Diagnostic Imaging, Thyroglobulin Stimulation and Therapy of Thyroid Cancer. | $345K | TROPHOGEN INC |
| Sep 21, 2020 | NIH | SBIR Phase II Novel Long Acting rhTSH Superagonist Analogs for Improved Diagnostic Imaging, Thyroglobulin Stimulation and Therapy of Thyroid Cancer. | $434K | TROPHOGEN INC |
| Apr 2, 2020 | NIH | SBIR Phase II Novel Recombinant High-Affinity, Long- and Dual-Acting Equine CG Analogs for Improved and More Ethical Reproduction in Pigs and Cattle | $728K | TROPHOGEN INC |
| Sep 4, 2019 | NIH | SBIR Phase II Novel Long Acting rhTSH Superagonist Analogs for Improved Diagnostic Imaging, Thyroglobulin Stimulation and Therapy of Thyroid Cancer. | $779K | TROPHOGEN INC |
| Apr 16, 2019 | NIH | SBIR Phase II Development of Novel and Affordable Neoglycosylated, Long Acting Superactive Analog of Human FSH for Infertility | $943K | TROPHOGEN INC |
| Mar 21, 2019 | NIH | SBIR Phase II Novel Recombinant High-Affinity, Long- and Dual-Acting Equine CG Analogs for Improved and More Ethical Reproduction in Pigs and Cattle | $733K | TROPHOGEN INC |
| Aug 1, 2018 | NIH | SBIR Phase II Novel Long Acting rhTSH Superagonist Analogs for Improved Diagnostic Imaging, Thyroglobulin Stimulation and Therapy of Thyroid Cancer. | $285K | TROPHOGEN INC |
| Mar 1, 2018 | NIH | SBIR Phase II Development of Novel and Affordable Neoglycosylated, Long Acting Superactive Analog of Human FSH for Infertility | $825K | TROPHOGEN INC |
| Sep 18, 2017 | NIH | SBIR Phase I Novel Recombinant High-Affinity, Long- and Dual-Acting Equine CG Analogs for Improved and More Ethical Reproduction in Pigs and Cattle | $139K | TROPHOGEN INC |
| Aug 18, 2017 | NIH | SBIR Phase II Development of Novel and Affordable Neoglycosylated, Long Acting Superactive Analog of Human FSH for Infertility | $300K | TROPHOGEN INC |
| Jun 4, 2015 | NIH | SBIR Phase II Novel High Affinity VEGF Analogs For Targeted Imaging of Thyroid Cancer | $766K | TROPHOGEN INC |
Peer ranks
Federal funding#170
Awards as PI#106
Patents#273
Companies
- TROPHOGEN INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.